DRTS
Alpha Tau Medical Ltd.
There isn't enough reported data to score DRTS yet.
DRTS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
DRTS's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
DRTS PE Valuation
DRTS has no meaningful PE right now: it lost money over the past year.
DRTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect DRTS's revenue to grow, with its earnings and profitability holding steady.
DRTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.04 | -$0.55 |
| Q1 2026 | -$0.67 | -$0.20 |
| Q4 2025 | -$0.53 | -$0.07 |
| Q3 2025 | -$0.53 | -$0.10 |
| Q2 2025 | -$0.49 | -$0.09 |
| Q1 2025 | -$0.47 | -$0.05 |
| Q4 2024 | -$0.46 | -$0.03 |
| Q3 2024 | -$0.43 | -$0.06 |
DRTS lost $1.04 per share over the past year, a bigger loss than the year before.
DRTS Quarterly Revenue
DRTS's revenue is shrinking: $0 last quarter.
DRTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | -$32.8M | -$32.8M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
DRTS's free cash flow was −$33M over the past year, against $0 the year before.
DRTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.4% | +1.2M shares |
| 1 year | +13% | +10.5M shares |
| 3 years | +31% | +21.6M shares |
| 5 years | +35% | +23.3M shares |
| Available history | +35% | +23.3M shares |
DRTS has 91M diluted shares, up 13% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
DRTS hasn't bought back shares in the past year.
DRTS Net Leverage
DRTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DRTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.0 | Neutral |
| Stochastic | 44.1 | Neutral |
DRTS's weekly RSI is 55 (neutral) and its Stochastic is 44 (neutral).
DRTS PE vs Healthcare Sector
DRTS has no meaningful PE right now: it lost money over the past year.
DRTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.7 | 2.2% below |
| 20 week MA | $13.7 | 2.8% below |
| 50 week MA | $10.0 | 33% above |
| 100 week MA | $6.65 | 101% above |
| 200 week MA | $4.84 | 176% above |
DRTS has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 176% above its 200-week average.
DRTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $9.79 | $9.86 | +0.7% |
| 2022 | $9.86 | $3.05 | -69% |
| 2023 | $3.05 | $3.01 | -1.3% |
| 2024 | $3.01 | $3.09 | +2.7% |
| 2025 | $3.09 | $5.10 | +65% |
| 2026 YTD | $5.10 | $13.4 | +162% |
DRTS has finished higher in three of the last five years. It's up 162% so far in 2026.